Judy Henry: From Herbalist to Entrepreneur

Sep.08.2022
Judy Henry: From Herbalist to Entrepreneur
Judy Henry, Idaho entrepreneur, developed all-natural formulas mimicking addictive nicotine and SARMS, but is unable to sell due to FDA regulations.

Judy Henry, an entrepreneur from Idaho, USA, has had a lifelong passion for plants and herbs. She spent several years researching the benefits of herbal medicine for health and has developed it into a lifelong career.


I use plant-based products because I grew up with them and understand what they can do for our bodies," Henry said during the interview.


I truly believe that God has placed everything we need on this earth," she continued. "They are the culmination of knowledge from previous generations who embraced plant medicine because of the powerful impact it has on our overall well-being.


This belief guides the life of Judy Henry. Furthermore, this belief has developed into something unique for her. Sacred Body Botanicals is the result of her dedication. Her accomplishment is building a small, natural health and wellness brand, which ultimately grew into a laboratory for innovative products developed over the years.


As a former smoker, Henry saw an opportunity to improve health. Utilizing her expertise in herbal medicine, she created a series of all-natural formulas to mimic the pleasure of addictive nicotine. Henry patented several of these formulas, stating that they have attracted a broad customer base who have seen benefits in a short period of time.


One of the products is a nicotine-free e-liquid, which Henry claims is a nicotine detoxifier that can help people quit smoking.


She developed the NoNic product, which has had a promising start. She also launched a pilot program in the local community to offer workshops introducing customers to her NoNic product.


She said she has had success introducing her NoNic formula to clients struggling with nicotine addiction in a few short meetings. Henry pointed out that due to FDA regulations, the product has not undergone medical review and she cannot promote its health benefits. However, she said some of her clients have provided positive feedback. One story she shared with me was particularly notable. A gentleman started using the NoNic formula and claimed he immediately became addicted to it, never smoking again. She has seen real-life success with NoNic.


However, the harsh reality is that selling plant-based formulations in the United States is illegal without invasive and expensive FDA inspections and approvals or other bans on products not federally approved. Despite creating a product that is almost entirely different from others on the market, the law forbids Henry from selling NoNic through her company, Sacred Body Botanicals.


In 2020, the United States Congress passed the controversial Preventing Online Sales of E-Cigarettes to Children Act, which amended the Prevent All Cigarette Trafficking (PACT) Act of 2009. The new law allows the Federal Alcohol, Tobacco, and Firearms (ATF) agency to actively enforce rules governing the interstate sale of tobacco products. The Preventing Online Sales of E-Cigarettes to Children Act expands upon the existing PACT Act by including a broad definition that encompasses e-cigarette devices and includes a ban on e-cigarette mailings enforced by the United States Postal Service.


Disclaimer: 1. This article is compiled from third-party information, and is only provided for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article content. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of compilation skills, the compiled article may not express the same meaning as the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions, 2FIRSTS fully aligns with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
One year after the UK disposable vape ban came into force, local authorities continue to seize illegal and non-compliant vaping products. FOI data compiled by nicotine retailer Northerner shows more than 1.3 million products were seized between June 2025 and May 2026, with Bolton recording the highest number of seizures and Swansea reporting the highest estimated value.
Jul.21
Minnesota Sues Loon as State Enforcement Targets U.S. Vape Brand Operators
Minnesota Sues Loon as State Enforcement Targets U.S. Vape Brand Operators
Minnesota Attorney General Keith Ellison sued Maduro Distributors, Inc., doing business as Loon, on July 15, 2026, alleging that the company illegally manufactured, distributed and sold flavored vapes that appeal to minors.
Jul.16
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
U.S. premium cigar culture is shifting toward education, broader choice and deeper links to craftsmanship and origin, cigar educator Mechelle Merkerson told 2Firsts. She sees boutique brands, women consumers and production-region experiences making knowledge central to cigar participation. For global brands, retailers and emerging markets such as China, education may help turn curiosity into sustained engagement.
Special Report
Jul.06
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
DOJ Trade Fraud Task Force Tops $1 Billion in Cases, Putting Vape Supply Chains at Risk of Fraud Enforcement
DOJ Trade Fraud Task Force Tops $1 Billion in Cases, Putting Vape Supply Chains at Risk of Fraud Enforcement
According to the U.S. Department of Justice (DOJ), Fox News and other reports, the DOJ’s Trade Fraud Task Force (TFTF) has been linked to more than $1 billion in recoveries, penalties, forfeitures and publicly charged losses in less than one year. The task force focuses on trade fraud issues including country-of-origin fraud, illegal transshipment, false declarations and tariff evasion. While vape products are not the main source of the $1 billion figure, the industry’s reliance on global manufacturing and cross-border supply chains places it within broader U.S. trade enforcement scrutiny. The development suggests that U.S. oversight of cross-border vape products may increasingly extend beyond product authorization into import compliance, supply-chain transparency and corporate accountability.
Jul.23
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18